Search results
Nuvama bets on these six stocks to make it to the MSCI index in August review
CNBC Awaaz· 5 days agoDixon Tech and Voda Idea are seen as the two biggest recipients of inflows, projected to garner $274...
Sell Indus Tower; target of Rs 270: ICICI Securities
CNBC Awaaz· 2 days agoICICI Securities is bearish on Indus Tower has recommended sell rating on the stock with a target price of Rs 270 in its research report dated July 04,...
Buy UltraTech Cement; target of Rs 13,000: Sharekhan
CNBC Awaaz· 5 days agoSharekhan is bullish on UltraTech Cement has recommended buy rating on the stock with a target price of Rs 13,000 in its research report dated June 28,...
Shivalic Power Control stock soars 221% on market debut on NSE SME platform
CNBC Awaaz· 5 days agoThe SME IPO, entirely a fresh equity issue of 64.3 lakh shares, received a strong response from...
ICICI Lombard hits new record high on CLSA upgrade, forecasts 7% upside potential
CNBC Awaaz· 3 days agoCLSA upgraded ICICI Lombard to 'outperform' from 'hold' and raised target price to Rs 2,000 per ...
IREDA stock jumps 6% to record high after a large deal; more than double investors' money YTD
CNBC Awaaz· 3 days agoShares of IREDA jumped nearly 6 percent on July 3 to touch an all-time high of Rs 218.85 on the...
Vraj Iron and Steel makes positive debut, lists at 16% premium over IPO price
CNBC Awaaz· 3 days agoThe Rs 171-crore initial public offering (IPO) saw remarkable investor interest over three days,...
Kaya stock locked at 10% upper circuit on marketing collaboration with Marico
CNBC Awaaz· 2 days agoShares of dermatological solutions provider Kaya were locked in the 10 percent upper circuit after...
PFC, REC get 'buy' rating from Bernstein; up to 23% upside seen in power financier stocks
CNBC Awaaz· 3 days agoREC has delivered multibagger returns of 224 percent in one year, more than quadrupling investors'...
Emcure Pharma IPO: Issue subscribed 29% on Day 1 so far; NIIs lead from the front
CNBC Awaaz· 3 days agoA day before the drugmaker's public offer went live, Emcure Pharmaceuticals raised Rs 582.6 crore...